Avinger slashes jobs, Q3 sales down 61%

Avinger (Nasdaq:AVGR) – maker of the Lumivascular image-guided, catheter-based system to treat peripheral artery disease (PAD) – continued to experience declining sales as it retrenched during the third quarter, according to its newest earnings report. The Redwood, Calif.–based company has been cutting jobs and other costs – and focusing on existing accounts and winning FDA clearance

Medtronic is closer to VenaSeal coverage: Here’s how

Medtronic is touting its new CPT codes for the VenaSeal varicose vein closure device – codes that company officials think bring the device closer to positive coverage from public and private insurers in the U.S. CMS announced the new codes on Nov. 1 as part of final rules for the 2018 Medicare Physician Fee Schedule (CMS-1676-F)

This nerve-blocking treatment could treat asthma and heart failure

Electrical nerve-blocking implants could help treat asthma and heart failure, according to new research from Case Western Reserve University. Niloy Bhadra and Kevin Kilgore, professors of biomedical engineering and orthopedic surgery respectively, have been working on the nerve-blocking research since 2000. The research blocks unwanted generation of nerve impulses in a variety of clinical applications.

These 7 antique medical devices will make you shudder

It’s a good thing we live in the times of modern medicine. Historically, medical devices have been scary and unorthodox – and sometimes amounted to downright quackery. Surprisingly, a lot of these devices were thought to be useful in their era, long before the U.S. FDA started preapproving devices (which wasn’t until the 1970s). You

Pages: 1 2 3 4 5 6 7 8

The top 10 medical disruptors of 2018

Each year the Cleveland Clinic determines what the top 10 disruptors in healthcare will be for the following year. The criteria to be considered a disruptor is that it has to be so innovative that it could change healthcare in a significant way in the next year. Approximately 150 to 200 Cleveland Clinic physicians from

Pages: 1 2 3 4 5 6 7 8 9 10 11

Imagining the future of heart pump technology

Dr. John O’Connell, VP, Medical Affairs & Medical Director, Mechanical Circulatory Support, Abbott Since its introduction more than 50 years ago, the left ventricular assist device has evolved from being a temporary solution to a long-term option for patients recovering from heart failure. Now, companies are engineering the LVAD of the future to be smaller

Medtech stories we missed this week: Oct. 20, 2017

From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD inks Chile distribution deal InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime

The 11 most innovative medical devices of 2017

The nominees for the best medical technology of 2017 were recently announced for the 11th Annual Prix Galien USA Awards. The Galien Foundation, the host of the awards, hands out the the Prix Galien Award annually to examples of outstanding biomedical and technology product achievement designed to improve human condition. Before candidates can qualify for

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

How Abiomed became a major medical device company

Abiomed has quickly climbed MDO’s Big 100 list, landing this year at 90th, and it has done so without major acquisitions. Fueling the global medtech company’s growth is a device with unique indications and a patient-centered business strategy. More than 60,000 patients have been treated using Abiomed’s Impella heart pumps – and every time the

Pediatric cardiac patients have better quality of life with ECMO

A new study has shown that cardiac patients who have been treated for extracorporeal membrane oxygenation (ECMO) have had overall favorable outcomes among survivors. ECMO gives breathing and heart support to critically ill children – artificially removing carbon dioxide and oxygenating red blood cells outside the body – while doctors treat other illnesses, according to

This cardiac catheter uses light and ultrasound to measure plaques

Researchers at the University of California at Davis combined ultrasound with light into a catheter probe to view the tiny arteries of the heart. The device uses intravascular ultrasound and fluorescence lifetime imaging (FLIm) to retrieve structural and biochemical information about plaque in the arteries to help predict heart attacks more reliably, according to the

This app turns your smartphone into an ultrasound to measure heart health

Engineers at the California Institute of Technology have turned a smartphone camera into an ultrasound to non-invasively give detailed information about someone’s heart health. Ultrasound scans take 45 minutes using the machine. Using the Caltech-developed app, the procedure is cut down to a minute or two. Huntington Medical Research Institute engineers created a technique that

Edwards Lifesciences has ‘key events’ around TAVR this week

Edwards Lifesciences is planning some important TAVR reveals during the PCR London Valves 2017 course that is underway. The Irvine, Calif.–based cardio devices company said yesterday that it plans to introduce the new Sapien 3 Ultra valve during the event, which runs until tomorrow. Edwards officials expect the Sapien 3 Ultra to receive CE Mark

How Abbott is making good on investor promises

Abbott (NYSE: ABT) has won FDA approval of MR-compatible ICDs – an indication that it could be making good executing on key priorities it inherited when it acquired St. Jude Medical for $25 billion early this year. The news today “lends incremental credibility to our thesis that ABT can and will have a positive impact on STJ

The startup pivot: How to rethink your medical device company

In the medtech market, startups have to be flexible; the startup pivot is crucial. “Companies have to morph as they go,” said Maria Palasis, CEO of bioresorbable drug delivery system company 480 Biomedical. Palasis explained that startups, and even mature companies should expect to shift their technology in one way or another through the course of